WB

Walgreens Boots Alliance IncNASDAQ WBA Stock Report

Last reporting period 31 Aug, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

7.364

Middle

Exchange

XNAS - Nasdaq

WBA Stock Analysis

WB

Uncovered

Walgreens Boots Alliance Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

1/100

Low score

Market cap $B

7.364

Dividend yield

11.79 %

Shares outstanding

862.5 B

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 200,000 full-time employees. The company went IPO on 2014-12-31. The firm operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The firm's U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

View Section: Eyestock Rating